What these researchers are doing with Fc sialylation sounds quite similar to what MNTA claims to be doing to enhance IVIG.
Fortunately for MNTA, it owns IP related to sialylation tweaking by virtue of the Virdante acquisition. Thus, if something comes out of the academic research cited by GG, it might be a source of licensing revenue for MNTA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”